Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DM0201 patch for postherpetic neuralgia
CTR20260516Phase 2Active
- Sponsor
- Demo High-Tech
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in postherpetic neuralgia (PHN), sponsored by Demo High-Tech. Started Feb 2026; status: active.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on CTR20260516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260516.